Patents by Inventor Sandra C. Miller

Sandra C. Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100260871
    Abstract: The invention is directed to a method of treating hematological malignancies by administering to the subject ginseng fractions from North American ginseng (Panax quinquefolium). The present invention can be used to activate the proliferation of hemopoietic cells in a patient in need of treatment, or as a therapeutic targeted at conditions characterized by hematological malignancy, such as an abnormal proliferation of blood cells, lymphocytes, multiple myeloma, etc. The invention also includes a method of treating leukemia by activating the proliferation of natural killer (NK) cells and monocytes in the bone marrow and the spleen of the patient by administering at least one ginseng fraction selected from the group consisting of CVT-E002, PQ2, PQ223 and purified fractions from CVT-E002, PQ2 and PQ223. The present invention may be used to treat the hematological malignancy or as a supplement for patients undergoing chemotherapy or radiation therapy.
    Type: Application
    Filed: May 16, 2007
    Publication date: October 14, 2010
    Applicant: Fx Life Sciences AG
    Inventors: Jacqueline Shan, Sandra C. Miller
  • Publication number: 20100221365
    Abstract: The invention is directed to ginseng fractions, methods of preventing or reducing hematological malignancies such as leukemia, and methods of elevating NK cells in a subject by administering to the subject an effective amount of a ginseng fraction, a pharmaceutical composition comprising the fraction in combination with another medicament or with one or more pharmaceutically acceptable carriers including food items. The fraction may be made from Panax quinquefolius or may be selected from CVT-E002, PQ2, PQ223 and purified fractions from CVT-E002, PQ2 and PQ223.
    Type: Application
    Filed: February 27, 2009
    Publication date: September 2, 2010
    Applicant: AFEXA LIFE SCIENCES INC.
    Inventors: Sandra C. Miller, Jacqueline Shan